血管生成抑制剂联合厄洛替尼靶向治疗 EGFR 突变进展期非小细胞肺癌的疗效和安全性：一项 Meta 分析
余家洋, 王春光
Efficacy and safety of angiogenesis inhibitor combined with erlotinibin the targeted treatment of EGFR-mutated advanced non-small celllung carcinoma: a Meta-analysis
YU Jiayang, WANG Chunguang
肿瘤
.
2023, (01): 29
-41
.
DOI: 10.3781/j.issn.1000-7431.2023.2205-0334
